Aşırı Aktif Mesane

Özet

Referanslar

White, N. and C.B. Iglesia, Overactive Bladder. Obstet Gynecol Clin North Am, 2016. 43(1): p. 59-68.

Kinsey, D., et al., The psychological impact of overactive bladder: a systematic review. Journal of health psychology, 2016. 21(1): p. 69-81.

Milsom, I., et al., How widespread are the symptoms of an overactive bladder and how are they managed? A population‐based prevalence study. BJU international, 2001. 87(9): p. 760-766.

Eapen, R.S. and S.B. Radomski, Review of the epidemiology of overactive bladder. Res Rep Urol, 2016. 8: p. 71-6.

Abrams, P., et al., The standardization of terminology of lower urinary tract function: report from the standardization sub-committee of International Continence Society, in Textbook of female urology and urogynecology. 2010, CRC Press. p. 1098-1108.

Peyronnet, B., et al., A comprehensive review of overactive bladder pathophysiology: on the way to tailored treatment. European urology, 2019. 75(6): p. 988-1000.

Kwon, J., et al., Pathophysiology of Overactive Bladder and Pharmacologic Treatments Including beta3-Adrenoceptor Agonists -Basic Research Perspectives. Int Neurourol J, 2024. 28(Suppl 1): p. 12-33.

de Groat, W.C., A neurologic basis for the overactive bladder. Urology, 1997. 50(6): p. 36-52.

Andersson, K.-E. and R. Pehrson, CNS involvement in overactive bladder: pathophysiology and opportunities for pharmacological intervention. Drugs, 2003. 63: p. 2595-2611.

Sakakibara, R., et al., Micturitional disturbance after acute hemispheric stroke: analysis of the lesion site by CT and MRI. Journal of the neurological sciences, 1996. 137(1): p. 47-56.

Yokoyama, O., et al., Influence of anesthesia on bladder hyperactivity induced by middle cerebral artery occlusion in the rat. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 1997. 273(6): p. R1900-R1907.

Shefchyk, S.J., Spinal cord neural organization controlling the urinary bladder and striated sphincter. Progress in brain research, 2002. 137: p. 71-82.

Morrison, J., W. Steers, and A. Brading, Neurophysiology and neuropharmacology/Abrams P, Khoury S, Wein A editors. Incontinence. Plimouth: Plymbridge Distributiors Ltd, 2002: p. 85-163.

Fernández, O., Mechanisms and current treatments of urogenital dysfunction in multiple sclerosis. Journal of neurology, 2002. 249: p. 1-8.

Sirls, L.T., P.E. Zimmern, and G.E. Leach, Role of limited evaluation and aggressive medical management in multiple sclerosis: a review of 113 patients. The Journal of urology, 1994. 151(4): p. 946-950.

Brading, A.F., A myogenic basis for the overactive bladder. Urology, 1997. 50(6): p. 57-67.

Sui, G., et al., Aberrant Ca2+ oscillations in smooth muscle cells from overactive human bladders. Cell Calcium, 2009. 45(5): p. 456-464.

de Groat, W.C., The urothelium in overactive bladder: passive bystander or active participant? Urology, 2004. 64(6): p. 7-11.

Moore, C.K. and H.B. Goldman, The bladder epithelium and overactive bladder: what we know. Current urology reports, 2006. 7(6): p. 447-449.

Shioyama, R., et al., Long-lasting breaches in the bladder epithelium lead to storage dysfunction with increase in bladder PGE2 levels in the rat. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008. 295(2): p. R714-R718.

Mahawong, P., et al., A role of intravesical capsaicin instillation in benign prostatic hyperplasia with overactive bladder symptoms: the first reported study in the literature. Medical journal of the Medical Association of Thailand, 2007. 90(11): p. 2301.

Robinson, D. and L. Cardozo, Overactive bladder: diagnosis and management. Maturitas, 2012. 71(2): p. 188-93.

Lightner, D.J., et al., Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment 2019. The Journal of urology, 2019. 202(3): p. 558-563.

Willis-Gray, M.G., A.A. Dieter, and E.J. Geller, Evaluation and management of overactive bladder: strategies for optimizing care. Research and reports in urology, 2016: p. 113-122.

Ciftci, S., et al., Urinary nerve growth factor and a variable solifenacin dosage in patients with an overactive bladder. International urogynecology journal, 2016. 27: p. 275-280.

Tsiapakidou, S., et al., The use of urinary biomarkers in the diagnosis of overactive bladder in female patients. A systematic review and meta-analysis. International Urogynecology Journal, 2021. 32(12): p. 3143-3155.

Scarneciu, I., et al., Overactive bladder: A review and update. Experimental and Therapeutic Medicine, 2021. 22(6): p. 1444.

Gormley, E.A., et al., Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. The Journal of urology, 2015. 193(5): p. 1572-1580.

Raju, R. and B.J. Linder. Evaluation and treatment of overactive bladder in women. in Mayo Clinic Proceedings. 2020. Elsevier.

Staskin, D., et al., Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder. International journal of clinical practice, 2010. 64(9): p. 1294-1300.

Chapple, C.R., et al., Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability. Neurourology and urodynamics, 2014. 33(1): p. 17-30.

Hsieh, P.-F., et al., Botulinum toxin A for the treatment of overactive bladder. Toxins, 2016. 8(3): p. 59.

Karsenty, G., et al., Botulinum toxin A (Botox®) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. European urology, 2008. 53(2): p. 275-287.

Kuo, H.-C., Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents. Urology, 2004. 63(5): p. 868-872.

Gaziev, G., et al., Percutaneous tibial nerve stimulation (PTNS) efficacy in the treatment of lower urinary tract dysfunctions: a systematic review. BMC urology, 2013. 13: p. 1-11.

Te Dorsthorst, M., M. van Balken, and J. Heesakkers, Tibial nerve stimulation in the treatment of overactive bladder syndrome: technical features of latest applications. Current Opinion in Urology, 2020. 30(4): p. 513-518.

Bhide, A.A., et al., Posterior tibial nerve stimulation for overactive bladder—techniques and efficacy. International urogynecology journal, 2020. 31: p. 865-870.

Spinelli, M. and K.-D. Sievert, Latest technologic and surgical developments in using InterStim™ therapy for sacral neuromodulation: impact on treatment success and safety. European urology, 2008. 54(6): p. 1287-1296.

Sukhu, T., M.J. Kennelly, and R. Kurpad, Sacral neuromodulation in overactive bladder: a review and current perspectives. Research and Reports in Urology, 2016: p. 193-199.

Gelecek

17 Nisan 2025

Lisans

Lisans